ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BMRN BioMarin Pharmaceutical Inc

65.66
0.00 (0.00%)
Pre Market
Last Updated: 09:31:26
Delayed by 15 minutes
Share Name Share Symbol Market Type
BioMarin Pharmaceutical Inc NASDAQ:BMRN NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 65.66 60.00 67.95 4 09:31:26

BioMarin to Host 2024 Investor Day on September 4th in New York

19/08/2024 2:00pm

PR Newswire (US)


BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart


From Jun 2024 to Dec 2024

Click Here for more BioMarin Pharmaceutical Charts.

-Event to be webcast live and a replay will be available

SAN RAFAEL, Calif., Aug. 19, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) will host an Investor Day with financial analysts and institutional investors on Wednesday, September 4, 2024, in New York City from 10:30 am to 1:00 pm Eastern Time.  The event will feature presentations from members of the executive management team and will highlight BioMarin's pipeline, strategic plans, growth opportunities and long-term financial outlook. 

BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)

BioMarin will host a live webcast on Wednesday, September 4, 2024, at approximately 10:30 am Eastern Daylight Time. Presentation materials will also be available at investors.biomarin.com. A replay of the webcast will be available online shortly after the live webcast is completed.

About BioMarin
Founded in 1997, BioMarin is a global biotechnology Company dedicated to transforming lives through genetic discovery. The Company develops and commercializes targeted therapies that address the root cause of genetic conditions. BioMarin's unparalleled research and development capabilities have resulted in eight transformational commercial therapies for patients with rare genetic disorders. The Company's distinctive approach to drug discovery has produced a diverse pipeline of commercial, clinical, and pre-clinical candidates that address a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a substantial benefit over existing treatment options. For additional information, please visit www.biomarin.com.

Contacts:


Investors

Media

Traci McCarty

Marni Kottle

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

(415) 455-7558

(650) 374-2803

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-host-2024-investor-day-on-september-4th-in-new-york-302224592.html

SOURCE BioMarin Pharmaceutical Inc.

Copyright 2024 PR Newswire

1 Year BioMarin Pharmaceutical Chart

1 Year BioMarin Pharmaceutical Chart

1 Month BioMarin Pharmaceutical Chart

1 Month BioMarin Pharmaceutical Chart